Effect of silymarin therapy on liver aminotransferase in non-alcoholic fatty liver disease
Medical Forum Monthly. 2015; 26 (12): 46-49
en Inglés
| IMEMR
| ID: emr-184729
ABSTRACT
Objective:
The present study evaluated the effects of silymarin on blood glucose, blood lipids and liver amino-transferase [AST and ALT] in Non-alcoholic fatty liver disease [NAFLD]
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Med. Forum Mon.
Año:
2015
Similares
MEDLINE
...
LILACS
LIS